In Saccharomyces cerevisiae, 3-amino-1,2,4-triazole (aminotriazole) competitively inhibits the activity of imidazoleglycerolphosphate dehydratase, the product of the HIS3 gene. Wild-type strains are able to grow in the presence of 10 mM aminotriazole because they induce the level of imidazoleglycerolphosphate dehydratase. However 
In the bakers' yeast Saccharomyces cerevisiae, the general control system coordinately regulates the expression of many genes encoding amino acid biosynthetic enzymes from different pathways (reviewed in references 12 and 16). Transcription of these genes is induced coordinately when yeast cells are starved for any one of several different amino acids. The coordinate induction is mediated by the binding of the GCN4 trascriptional activator protein to the promoter regions of amino acid biosynthetic genes (2, 15) . GCN4 binds as a dimer (1Sa) to target sites whose consensus is the 9-base-pair (bp) dyad ATGA(C/G)TCAT (10) . GCN4 protein is synthesized only when cells are starved for amino acids even though the mRNA is present under all conditions (11, 36) . This regulation of GCN4 protein levels, which occurs by a novel translational control mechanism, accounts for the fact that the amino acid biosynthetic genes are induced only during starvation conditions.
Extensive deletion analysis of the HIS3 promoter region
indicates that although the GCN4-binding site is required for induction, it is insufficient for maximal mRNA levels during amino acid starvation (33) . A separate element, which includes the TGCCTC sequence between -142 and -137 with respect to the transcriptional initiation site, is also required for wild-type induction levels. Although this sequence appears to be related to GCN4-binding sites, DNase I footprinting experiments indicate that its affinity for GCN4 is at least 50-fold lower than that of the primary binding site, and they showed no evidence for cooperativity (2, 15) . From this and several other observations, we proposed that yeast cells contain a DNA-binding protein that is distinct from GCN4, but which recognizes related but nonidentical sequences (33) . This protein, which was suggested from genetic experiments, may or may not be identical to a protein detected in crude extracts that binds near the GCN4-binding site in the HIS4 promoter (2) . The original purpose of the experiments described in this paper was to clone the gene encoding the hypothetical DNA-binding protein described above. We reasoned that cells containing an excess of this protein might show increased levels of HIS3 mRNA in the absence of GCN4. In principle, this increased expression could have been due to more efficient binding to the TGCCTC sequence between -137 and -142 and/or to the related GCN4-binding sequence. Thus, we attempted to identify a yeast gene that would cause increased HIS3 expression when present in multiple copies per cell in a gcn4 mutant strain.
The genetic selection for such a gene relied on the fact that gcn4 strains are unable to grow in medium containing 3-amino-1,2,4-triazole (aminotriazole), a competitive inhibitor of the HIS3 gene product, imidazoleglycerolphosphate (IGP) dehydratase (17, 31) . At a concentration of 10 mM, aminotriazole causes histidine starvation, but wild-type strains are able to grow because they induce HIS3 transcription and hence IGP dehydratase above the basal level. However, strains containing gcn4 mutations fail to grow under these conditions because they are unable to induce HIS3 expression in response to starvation (13, 24) . In this paper, we identify a new yeast gene (ATRJ) that when 664 present in multiple copies confers increased aminotriazole resistance. However, characterization of this gene strongly suggests that it does not encode the hypothetical transcription factor, but rather a membrane-associated protein that may be involved in the excretion of aminotriazole (and possibly other toxic compounds) out of the cell.
MATERIALS AND METHODS
Yeast strains. The yeast strains used in this study were KY114 (a ura3-52 ade2-101 trpl-Al lys2-801) (30) , S288C (wild type), KY413 (a leu2-2,112 gcn4-1) (derived from a strain obtained from Alan Hinnebusch) , and MP40A-8B (a ura3-52 gcn4-2). These strains and their derivatives were grown at 30°C either in YPD medium (1% yeast extract, 2% peptone, 2% glucose) or in minimal medium (0.67% yeast nitrogen base without amino acids, 2% glucose) with appropriate supplements at 2 ,ugIml. Unless otherwise specified, aminotriazole was added to a final concentration of 10 mM to minimal medium lacking histidine. Yeast strains were transformed with hybrid DNA molecules as described previously (30) .
Construction of hybrid DNA molecules. The procedures for constructing hybrid DNA molecules have been described previously (29) . To make the hybrid pools, we cloned 5-to 15- DNA fragments from the original plasmids containing ATR1, YEp13-Sc4018 and YEp24-Sc4020, were subcloned as follows. From YEp24-Sc4020, the 2.5-kb SphI fragment (Sc4021) was subcloned back into YEp24. From YEp13-Sc4018, the 1.8-kb BamHI-HindIII fragment (Sc4022), the 2.6-kb BamHI-EcoRI fragment (Sc4023), the 2.4-kb SacIHindIII fragment (Sc4024), and the 3.2-kb SacI-EcoRI fragment (Sc4025) were inserted into the relevant sites of YRp74. YRp74, a 3.4-kb vector constructed by a complex series of manipulations to be described elsewhere, contains the EcoRI-HindIII polylinker from M13mp18 (22), the 1.1-kb Hindlll fragment encoding the URA3 structural gene (3), the 350-bp Hindlll-Hincll fragment encoding the ARS1 chromosomal replicator (37) , and the 2.1-kb NdeI-EcoRI fragment encoding the ampicillin resistance gene from pBR322 (35) in which the origin of DNA replication has been replaced by equivalent sequences from the high-copy vector pUC9 (39 (39) .
Constructing yeast strains with atrl mutations. DNAs containing atrl mutations were cleaved with Spel to increase the integration frequency and to direct integration to the ATRI locus. DNAs purified by electrophoresis in low-gellingmelting-temperature agarose followed by phenol extraction were introduced into KY114 by selecting for Ura+ colonies. Transformants resulting from chromosomal integration of the introduced DNA were distinguished from those resulting from autonomous replication by assaying the mitotic stability of the Ura+ phenotype (34) . Colonies showing a stable Ura+ phenotype were then grown in YPD medium, and Ura-segregants were selected by virtue of their resistance to 5-fluoro-orotic acid (4) .
To determine which of the Ura-segregants were due to replacement of the ATRI locus by the atrl deletion mutations, we did genomic hybridization experiments as described previously (34) . Yeast To determine the 5' ends of ATR1 RNA, we performed S1 nuclease mapping essentially as described previously (32) . The (2. 75 mCi/mmol; ICN Radiochemicals) was added to 18 ,u of cells that had been prewarmed to 30°C. After 15 min of incubation at 30°C, 5 ,ul of cells was diluted into 1 ml of ice-cold medium, immediately filtered onto a pre-wet Whatman GF-A filter, and washed three times with 1.5 ml of ice-cold medium. The filters were dried under a heat lamp for 5 min, soaked in Liquiscint (National Diagnostics), and then analyzed in a Beckman LS 3801 scintillation counter. For comparing aminotriazole incorporation in different strains, the amount of radioactivity retained on the filter was normalized to the number of cells in the assay. Kinetic experiments indicated that incorporation of aminotriazole into cells proceeded linearly for approximately 10 min, at which time it remained constant for at least one more hour. Essentially no aminotriazole was incorporated when cells were incubated on ice.
RESULTS
Cloning of ATRI. Two independent hybrid pools were prepared, each consisting of genomic yeast DNA segments cloned into vectors containing the 2,um origin of replication. In one case, yeast DNA segments were cloned in YEp13, a vector containing the LEU2 gene (6) , and then introduced into KY413 (a leu2-2,112 gcn4-1). In the other case, yeast DNA was cloned in YEp24, a vector containing the URA3 gene (5), and then introduced into MP40A-8B (a ura3-52 gcn4-2). Leu+ or Ura+ transformants were selected and then screened for their ability to grow on medium containing 10 mM aminotriazole. Plasmid DNAs from several aminotriazole-resistant colonies were recovered and then reintroduced back into the appropriate strain. From each original hybrid pool, one cloned DNA segment allowed cells to grow at wild-type rates in medium containing 10 mM aminotriazole. Restriction mapping indicated that these two DNA molecules, YEp13-Sc4018 and YEp24-Sc4020, contained approximately 3.3 kb of DNA in common (Fig. 1 ). For reasons to be discussed below, we propose the gene designation ATRJ (aminotriazole resistance) to refer to the segment of DNA that confers aminotriazole resistance. Hybridization of 32P-labeled Sc4023 (a BamHI-EcoRI fragment; growth on 10 mM aminotriazole ( Fig. 1 Aminotriazole sensitivity of strains containing atr mutations. To gain further insight into the role of ATRI, we generated strains containing atr mutations by replacing the wild-type locus with mutant DNA. Two deleted derivatives of YRp74-Sc4025 (contains the 3.2-kb EcoRI-SacI ATR) fragment cloned in YRp74) were constructed (Fig. 2) . One deletion, atr)-Al, lacks the 495-bp SspI fragment within the ATR1 coding region. The other mutation, atrl-A2, lacks 1.8 kb of DNA between the BamHI and HindIII sites and hence represents almost a complete deletion of the ATTR) gene. The mutant DNAs were cleaved with Spel and introduced into KY114 (relevant genotype, ura3-52 HIS3 ATRI) by selecting for Ura+ colonies. Transformants resulting from chromosomal integration of the introduced DNA were grown in nonselective medium, and Ura-segregants were selected by growth on medium containing 5-fluoro-orotic acid (4). Genomic hybridization experiments indicated that 5 of 15 Urasegregants contained atr)-Al, whereas only 1 of 8 Urasegregants contained atrl-A2 (Fig. 2) . All six atrl deletion (lanes P to W). The sizes of the DNA fragments were calibrated with respect to standards produced by cleavage of bacteriophage X DNA with HindIII (data not shown).
strains were unable to grow in medium containing 10 mM aminotriazole, although they grew at wild-type rates in the absence of this inhibitor. A similar phenotype was observed when the ATRI gene was replaced by atrl-Ll, a derivative in which a 430-bp SphI fragment from bacteriophage X DNA was inserted into the SphI site (Fig. 2) . Thus, although ATR] is not essential for cell viability, loss of ATRI function causes strains to be hypersensitive to aminotriazole.
Effect ofATRi on resistance to other toxic compounds. The mammalian mdr and yeast PDR genes are involved in resistance to a number of apparently unrelated drugs (1, 7, 9, 27) . To determine whether ATR] is specific for aminotriazole resistance, we diluted saturated cultures of wild-type, atrlAl, atrl-A2, and YRp74-ATRJ strains to a concentration of approximately 50 cells per ,ul. For each condition to be examined, 1-,ul samples from each culture were spotted on a plate containing a toxic compound at a defined concentration. In this way, growth of the strains could be compared directly on the same plate by determining the size of the colonies after a given amount of time; artifacts due to cell density and reversion were avoided.
As expected, the strains behaved very differently in the presence of aminotriazole. Strains containing atrl deletions were almost completely inhibited at 10 mM and were partially inhibited even at 5 mM; this level of inhibition appeared somewhat less pronounced than that seen in gcn4 strains. Strains overproducing ATRI formed colonies in 2 to 3 days even in the presence of 80 mM aminotriazole. The growth of wild-type strains was completely inhibited at this concentration, strongly inhibited in 40 mM aminotriazole, and barely if at all inhibited at 20 mM (or lower). Thus, excess ATRI gene product confers super-resistance to aminotriazole.
In contrast, growth of these strains could not be distinguished in the presence of a variety of other toxic compounds over a range of different concentrations. The compounds tested included triazolealanine (resistant below 2 ,ug/ml and sensitive about 10 ,ug/ml), ethionine (resistant below 0.2 ,ug/ml and sensitive above 0.75 p.g/ml), canavanine (resistant below 0.2 jig/ml and sensitive above 1 ,ug/ml), cycloheximide (resistant below 0.2 jig/ml and sensitive above 1 ,ug/ml), chloramphenicol (resistant below 4 ,ug/ml and sensitive above 15 ,ug/ml), antimycin (resistant below 0.4 ,ug/ml and sensitive above 2 ,ug/ml), oligomycin (resistant below 0.5 ,ug/ml and sensitive above 3 ,ug/ml), p-fluorophenylalanine (resistant below 2 ,ug/ml and sensitive above 8 ,ug/ml), vinblastine (slighlty sensitive at 40 ,ug/ml), and daunomycin (slightly sensitive at 7 p.g/ml). Triazolealanine, ethionine, canavanine, and p-fluorophenylalanine respectively inhibit histidine, methionine, arginine, and phenylalanine biosynthesis; vinblastine inhibits mitosis; daunomycin, cycloheximide, and chloramphenicol inhibit protein synthesis; and antimycin and oligomycin block electron transport. Thus, the ATRI gene seems to be involved specifically in aminotriazole resistance and hence is unlikely to be allelic to yeast pdr mutations.
Regulation of ATRI transcription. Total RNA was prepared from wild-type cells grown under a variety of environmental conditions, electrophoretically separated in a denaturing agarose gel, transferred to nitrocellulose, and hybridized to 32P-labeled probes corresponding to the ATRI and URA3 genes (Fig. 3) . When cells were grown in the VOL. 8, 1988 668 KANAZAWA ET AL. were pelleted and suspended in medium containing 10 mM aminotriazole at time zero. RNA was then analyzed at the indicated times (in minutes) after addition of the inhibitor.
presence of 10 mM aminotriazole, a band corresponding to a 1.9-kb RNA species was observed; presumably, this represents transcription of ATRI. Interestingly, this band was not observed when cells were grown in minimal medium lacking aminotriazole in either the presence or absence of histidine or all 20 amino acids. When aminotriazole was added to a growing culture, ATRJ transcripts were observed as early as S min after the addition (Fig. 3) . Thus, ATR] transcription is regulated as a function of aminotriazole concentration.
This regulation ofATR] transcription could reflect a direct response to aminotriazole or a response by the GCN4-mediated general control system to the histidine limitation caused by aminotriazole. At least part of the response appears to involve the general control pathway because when leucine is added to 10 mM, a condition that inhibits valine and isoleucine biosynthesis (23), ATRI transcription is also induced (data not shown). However, the observationthat elevated levels ofATR] transcripts occur even in certain ik.,*_. , 7 . T . gcn mutant backgrounds (data not shown) suggests that something besides general control is also involved.
5'-end mapping of the ATRI transcript. Si nuclease mapping was used to localize the 5' end of ATRI RNA with respect to the cloned DNA region (Fig. 4) . Poly(A)+ RNA isolated from wild-type cells grown in the presence of aminotriazole was hybridized to the indicated 5'-end-labeled probes and treated with Si nuclease, and the products were subsequently analyzed by electrophoresis in denaturing acrylamide gels. Hybridization to the 1.8-kb MluI-HindIII fragment labeled at the MluI site generated a broad band approximately 800 nucleotides in length in addition to a band owing to reassociation of the probe. Hybridization to the same fragment labeled at the HindIII site did not produce a band other than that due to probe reassociation. This indicates that transcription proceeds from left to right from a site located about 800 bases away from the MluI site. Better resolution was obtained by hybridization to the 495-bp Sau3A fragment, which generated bands of 330 and 445 nucleotides; this locates two initiation sites that are, respectively, 330 and 445 + 5 bases away from the Sau3A site. The position of the more downstream initiation site was confirmed by hybridization to the 379-bp DdeI fragment which generated a band of 360 nucleotides (the band due to the other transcript comigrates with the band due to probe reassociation because the initiation site occurs upstream of the Sau3A site in the hybridization probe).
DNA and deduced amino acid sequence of ATRI. To define the structure of ATR1 more precisely, we determined the DNA sequence of both strands of the 3.3-kb XhoI-EcoRI fragment of YEp13-Sc4018 by the dideoxy chain termination method. The clones that were sequenced are shown in Fig.  5 , and the DNA sequence is shown in Fig. 6 .
Analysis of both strands of the DNA sequence revealed a single long open reading frame of 547 amino acids, and several lines of evidence strongly suggest that this is the primary ATRI translation product. First, the length and direction of this reading frame are consistent with the length 536 . From an analysis of ATPases, it has been proposed that G-(X)4-GK(T)-(X)6-I/N and R/K(X)3-G-(X)3-L-(hydrophobic)4-D represent a pair of sequences that constitute an ATP-binding fold (41 (Table 1) . When compared with the relative level of aminotriazole in a wild-type strain, the atrl deletion strain contained approximately twice as much aminotriazole, whereas the ATRI multiplecopy strain had only about half as much. Thus, it appears that increased aminotriazole resistance was inversely correlated with the intracellular concentration of aminotriazole. However, owing to the relatively small differences between strains, it was not possible to determine whether the differences in the steady-state level reflected alterations of transport into or out of the cell. DISCUSSION This paper describes the isolation and characterization of a new gene, ATRI, which is involved in the resistance to aminotriazole in the yeast S. cerevisiae. When compared with wild-type strains, cells with multiple copies of ATRI grow in very high concentrations of aminotriazole, whereas elimination of the gene causes cell growth to be inhibited at lower concentrations of the inhibitor. Thus, it appears that the level of aminotriazole resistance is determined bv the amount of ATRI gene product. In this sense, ATRi is analogous to dominant drug resistance genes of bacteria such as those involved in resistance to ampicillin, tetracycline, or chloramphenicol or to a mammalian gene involved in multidrug resistance. Perhaps ATRI will prove to be useful as a general selectable marker for transformation of S. cerevisiae (and possibly other eucaryotic) cells.
Structure of ATRI protein. From the sequence of the ATRI gene, we suggest that ATR1 is a transmembrane protein and propose a tentative structure (Fig. 8) . The hydropathy analysis shown in Fig. 7 utilizes stringent criteria for hydrophobic regions in that it was carried out with a window of 19 amino acids, a stretch that is large enough to span a membrane (19) . By this analysis, there are 12 separate regions of ATR1 protein with hydropathic values greater than +1.2, a number strongly indicative of a membranespanning region (8, 19) , and most of these regions are considerably more hydrophobic (nine are greater than + 1.5). The N terminus of ATR1 is very highly charged and hence does not resemble a signal sequence that is typically used for passage through the membrane (40) . Thus, we propose that the N-terminal region is oriented on the cytoplasmic side of the membrane. If the 12 hydrophobic regions represent six transmembrane loops, this would mean that the C terminus of ATR1 would also be oriented on the cytoplasmic side of the membrane.
In the proposed structure, two of the putative glycosylation sites (at positions 394 and 471) are predicted to occur on the extraceilular side of the membrane, the expected position. The other two sequences lie within the highly charged and intracellularly located N terminus and would not be expected to be glycosylated. Both sequences that make up the putative ATP-binding site would be located on the intracellular side as expected, although they would be separated by one transmembrane loop. With respect to the atrl deletion mutants, removal of theC-terminal 23 amino acids has a minor effect on function and does not disrupt the basic structure, whereas deletion of the C-terminal 34 amino acids destroys the last transmembrane region and abolishes ATRI function. The atri-Al mutation, which abolishes function, would remove five transmembrane domains and hence would lead to a faulty orientation of the protein.
A problem with the model in Fig. 8 is that one of the sequence motifs proposed to be part of the putative ATPbinding site is located at the extreme C terminus, a region that can be eliminated with only a minor loss of function. This could suggest that the ATR1 protein does not contain an ATP-binding site, that some other region besides the extreme C terminus acts with the conserved sequence between residues 426 to 440 to form an ATP-binding site, or that binding of ATP is not essential for ATRI function.
Models for ATRI function. In S. cerevisiae, it is believed that aminotriazole inhibits cell growth solely because it is a competitive inhibitor of IGP dehydratase, the HIS3 gene product (17, 31) . This belief stems primarily from the observation that aminotriazole does not inhibit growth when histidine is present in the medium. Given this assumption, there are three major factors that influence aminotriazole resistance: the level of the HIS3 gene product, the amount of IGP (the substrate that is competed by aminotriazole), and the amount of aminotriazole that enters the cell.
On the basis of these considerations, several models for ATR1 function can be proposed. There are several ways in which the ATRI gene product could reduce intracellular levels of aminotriazole. First, by analogy with the ampicillin and chloramphenicol resistance genes, which respectively encode P-lactamase and chloramphenicol transacetylase, ATR1 could encode an enzyme that degrades aminotriazole. We do not favor this explanation because hydrolytic enzymes are usually secreted rather than transmembrane proteins; in this regard, the hydrophilic and acidic nature of the N terminus of ATR1 argues against secretion of the protein (40) . Second, ATR1 could inhibit the uptake of aminotriazole. This seems unlikely because there are at least two routes for entry of aminotriazole into the cell (43) . Moreover, unlike CAN] which encodes an arginine permease and is involved in resistance to canavanine (42) , ATRI cannot encode a permease for aminotriazole because drug resistance is the dominant trait. Third, ATR1 could be involved in the passage of aminotriazole between the vacuole, the normal storage compartment for amino acids (21) , and the cytoplasm, where it would inhibit IGP dehydratase. Fourth, by analogy with the tetracycline resistance gene or with plasmid-encoded genes involved in resistance to cadmium or arsenate (20, 25, 28, 38) , ATR1 could encode a protein that is involved in actively pumping aminotriazole out of the cell. Such an active export mechanism, which we favor, has also been proposed for the mdr gene product that confers multidrug resistance in mammalian cells (1, 7, 9) . Perhaps, as has been suggested for the mdr gene product, active export of aminotriazole by ATR1 protein requires the hydrolysis of ATP. However, ATRI appears to differ from mdr in that resistance does not occur to a variety of drugs but rather appears specific to aminotriazole.
Comments on the physiological role of ATRi. Although drug resistance conferred by ATR1 seems to be specific for aminotriazole, it is difficult to believe that yeast cells have evolved a gene whose normal physiological role is to export a compound not found in nature. A clue to the normal function may come from the observation that ATRI appears to be a gene that is subject to general control; i.e., expression is induced coordinately with many genes involved in amino acid biosynthesis, and the promoter region contains a GCN4-binding site. It seems likely that cells containing high levels of amino acid biosynthetic enzymes will accumulate precursors to amino acids, some of which may be toxic. Perhaps S. cerevisiae has maintained the ATR1 gene to excrete such toxic compounds that may arise upon severe metabolic stress. Alternatively, ATR] may play an important role in pumping out toxins that cells may encounter in the natural environment. Another possible physiological role for ATRI could be to regulate the transport of amino acids between the vacuole and the cytoplasm; such a process would certainly be sensitive to changes in the amino acid biosynthetic capacity of the cell such as those controlled by GCN4. However, for any of these potential roles, the natural substrates for ATR1 are unknown.
